CMS advises BKS on sale of food supplements provider Vitamaze to Vision Healthcare

Frankfurt/Main – BKS eG has sold all its shares in Vitamaze GmbH to Vision Healthcare NV. Vitamaze is a leading European e-commerce provider of vitamins, minerals, and supplements (VMS) operating mainly through Amazon and e-pharma channels, in particular online pharmacies. The transaction also includes the US subsidiary of Vitamaze GmbH, Vispura. Vision Healthcare NV is a Belgian company focusing on consumer healthcare, including direct-to-consumer VMS platforms. Details of the transaction were not disclosed.

A CMS team headed by lead partner Dr Hendrik Hirsch advised BKS on all legal aspects of the deal, including regulatory issues.

CMS Germany

Dr Hendrik Hirsch, Lead Partner, Frankfurt/Main
Dr Dirk Baukholt, Counsel, Frankfurt/Main
Maxine Notstain, Senior Associate, Frankfurt/Main, all Corporate/M&A
Jörg Schrade, Partner, Munich, Tax
Kai Neuhaus, Partner, Brussels
Moritz Pottek, Senior Associate, Brussels, both Competition & EU
Dr Dirk Smielick, Counsel, Cologne, Intellectual Property

Press Contact
presse@cms-hs.com